| For: | Lange F, Rateitschak K, Kossow C, Wolkenhauer O, Jaster R. Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach. World J Gastroenterol 2012; 18(43): 6226-6234 [PMID: 23180942 DOI: 10.3748/wjg.v18.i43.6226] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i43/6226.htm |
| Number | Citing Articles |
| 1 |
X.Y. Lan, H.Y. Sun, J.J. Liu, Y. Lin, Z.Y. Zhu, X. Han, X. Sun, X.R. Li, H.C. Zhang, Z.Y. Tang. Effects of Garlic Oil on Pancreatic Cancer Cells. Asian Pacific Journal of Cancer Prevention 2013; 14(10): 5905 doi: 10.7314/APJCP.2013.14.10.5905
|
| 2 |
Jakob Brandstetter, Lea Goldstein, Tim Schreiber, Rupert Palme, Tobias Lindner, Markus Joksch, Bernd Krause, Brigitte Vollmar, Simone Kumstel, Yoshihiro Sowa. Targeting pancreatic cancer with combined inhibition of EGFR and RAF. PLOS One 2026; 21(4): e0347843 doi: 10.1371/journal.pone.0347843
|
| 3 |
Mohamed A. Omar, Jürgen Conrad, Uwe Beifuss. Assembly of 4H-chromenes, imidazobenzothiazines and quinazolines via copper-catalyzed domino reactions using 2-halobenzyl tosylates as substrates. Tetrahedron 2014; 70(35): 5682 doi: 10.1016/j.tet.2014.06.071
|
| 4 |
Seong Joon Park, Seung-Mi Kim, Jai-Hee Moon, Jeong Hee Kim, Jae-Sik Shin, Seung-Woo Hong, Yu Jin Shin, Dae-Hee Lee, Eun Young Lee, Ih-Yeon Hwang, Jeong Eun Kim, Kyu-pyo Kim, Yong Sang Hong, Won–Keun Lee, Eun Kyung Choi, Jung Shin Lee, Dong-Hoon Jin, Tae Won Kim. SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin. Tumor Biology 2016; 37(4): 4323 doi: 10.1007/s13277-015-4216-2
|
| 5 |
Mohamed A. Omar, Jürgen Conrad, Uwe Beifuss. Copper-catalyzed domino reaction between 1-(2-halophenyl)methanamines and amidines or imidates for the synthesis of 2-substituted quinazolines. Tetrahedron 2014; 70(18): 3061 doi: 10.1016/j.tet.2014.02.066
|
| 6 |
K Kajiyama, M Okada‐Hatakeyama, Y Hayashizaki, H Kawaji, H Suzuki. Capturing Drug Responses by Quantitative Promoter Activity Profiling. CPT: Pharmacometrics & Systems Pharmacology 2013; 2(9): 1 doi: 10.1038/psp.2013.53
|
| 7 |
C S Monast, M J Lazzara. Identifying Determinants of EGFR‐Targeted Therapeutic Biochemical Efficacy Using Computational Modeling. CPT: Pharmacometrics & Systems Pharmacology 2014; 3(10): 1 doi: 10.1038/psp.2014.39
|
| 8 |
Changyi Chen. Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicine. Medical Science Monitor 2013; 19: 916 doi: 10.12659/MSM.889636
|
| 9 |
Falko Lange, Benjamin Franz, Claudia Maletzki, Michael Linnebacher, Maja Hühns, Robert Jaster. Biological and Molecular Effects of Small Molecule Kinase Inhibitors on Low-Passage Human Colorectal Cancer Cell Lines. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/568693
|
| 10 |
Prashant Dogra, Javier R. Ramírez, María J. Peláez, Zhihui Wang, Vittorio Cristini, Gulshan Parasher, Manmeet Rawat. Mathematical Modeling to Address Challenges in Pancreatic Cancer. Current Topics in Medicinal Chemistry 2020; 20(5): 367 doi: 10.2174/1568026620666200101095641
|
| 11 |
Kovuru Gopalaiah, Anupama Saini, Alka Devi. Iron-catalyzed cascade reaction of 2-aminobenzyl alcohols with benzylamines: synthesis of quinazolines by trapping of ammonia. Organic & Biomolecular Chemistry 2017; 15(27): 5781 doi: 10.1039/C7OB01159H
|
| 12 |
Jing Du, Yuanqiao He, Weiquan Wu, Peng Li, Youwei Chen, Zhiming Hu, Yong Han. Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer. Journal of Pharmacy and Pharmacology 2019; 71(2): 196 doi: 10.1111/jphp.12941
|
| 13 |
Julio Vera, Olaf Wolkenhauer, Ulf Schmitz. Encyclopedia of Life Sciences. 2014; doi: 10.1002/9780470015902.a0025237
|
| 14 |
Christian Klopsch, Anna Skorska, Marion Ludwig, Heiko Lemcke, Gabriela Maass, Ralf Gaebel, Martin Beyer, Cornelia Lux, Anita Toelk, Karina Müller, Christian Maschmeier, Sarah Rohde, Petra Mela, Brigitte Müller-Hilke, Stefan Jockenhoevel, Brigitte Vollmar, Robert Jaster, Robert David, Gustav Steinhoff. Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart. Disease Models & Mechanisms 2018; doi: 10.1242/dmm.033282
|